BioCentury
ARTICLE | Company News

AvidBiologics, National Research Council (NRC) Canada deal

February 4, 2013 8:00 AM UTC

AvidBiologics partnered with the NRC to jointly develop three antibody-drug conjugates (ADC) against undisclosed targets to treat cancer. The antibodies were generated as part of the NRC's integrated ...